Works matching AU Chul Won Choi


Results: 100
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Clinical outcomes and prognostic factors inpatients with breast diffuse large B cell lymphoma;Consortium for Improving Survival of Lymphoma(CISL) study.

    Published in:
    BMC Cancer, 2010, v. 10, p. 321, doi. 10.1186/1471-2407-10-321
    By:
    • Ho-Young Yhim;
    • Hye Jin Kang;
    • Yoon Hee Choi;
    • Seok Jin Kim;
    • Won Seog Kim;
    • Yee Soo Chae;
    • Jin Seok Kim;
    • Chul Won Choi;
    • Sung Yong Oh;
    • Hyeon Seok Eom;
    • Jeong-A Kim;
    • Jae Hoon Lee;
    • Jong-Ho Won;
    • Hyeok Shim;
    • Je-Jung Lee;
    • Hwa Jung Sung;
    • Hyo Jung Kim;
    • Dae Ho Lee;
    • Cheolwon Suh;
    • Jae-Yong Kwak
    Publication type:
    Article
    10

    Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non‐Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma.

    Published in:
    Transplant International, 2020, v. 33, n. 10, p. 1211, doi. 10.1111/tri.13664
    By:
    • Kim, Kyoung Ha;
    • Kim, Won Seog;
    • Kim, Seok Jin;
    • Yoon, Dok Hyun;
    • Suh, Cheolwon;
    • Kang, Hye Jin;
    • Choi, Chul Won;
    • Lee, Ho Sup;
    • Bae, Sung Hwa;
    • Park, Jinny;
    • Park, Eun Kyung;
    • Kwak, Jae‐Yong;
    • Lee, Mark Hong;
    • Kang, Byung Woog;
    • Park, Sung‐Kyu;
    • Won, Jong‐Ho
    Publication type:
    Article
    11
    12

    Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group.

    Published in:
    Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 4199, doi. 10.1007/s10238-023-01189-9
    By:
    • Gill, Harinder;
    • Leung, Garret M. K.;
    • Ooi, Melissa G. M.;
    • Teo, Winnie Z. Y.;
    • Wong, Chieh-Lee;
    • Choi, Chul Won;
    • Wong, Gee-Chuan;
    • Lao, Zhentang;
    • Rojnuckarin, Ponlapat;
    • Castillo, Ma. Rosario Irene D.;
    • Xiao, Zhijian;
    • Hou, Hsin-An;
    • Kuo, Ming-Chung;
    • Shih, Lee-Yung;
    • Gan, Gin-Gin;
    • Lin, Chien-Chin;
    • Chng, Wee-Joo;
    • Kwong, Yok-Lam
    Publication type:
    Article
    13
    14
    15
    16
    17
    18

    The outcomes of Korean Patients With Primary Plasma Cell Leukemia: Analysis of Korean Multiple Myeloma Working Party (KMM160).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e38, doi. 10.1016/j.clml.2017.03.067
    By:
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Kihyun;
    • Suh, Cheolwon;
    • Yoon, Do Hyun;
    • Min, Chang Ki;
    • Sohn, Sang Kyun;
    • Choi, Chul Won;
    • Lee, Ho Sup;
    • Kim, Hyo Jung;
    • Shin, Ho-Jin;
    • Bang, Soo-Mee;
    • Yoon, Sung-Soo;
    • Park, Seong Kyu;
    • Yhim, Ho-Young;
    • Kim, Min Kyoung;
    • Jo, Jae-Cheol;
    • Mun, Yeung-Chul;
    • Lee, Jae Hoon;
    • Kim, Jin Seok
    Publication type:
    Article
    19
    20
    21

    Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.

    Published in:
    Cancer Science, 2010, v. 101, n. 11, p. 2443, doi. 10.1111/j.1349-7006.2010.01698.x
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Jin Seok;
    • Kim, Seok Jin;
    • Lee, Suee;
    • Lee, Dae Ho;
    • Won, Jong-Ho;
    • Hwang, In Gyu;
    • Kim, Min Kyoung;
    • Lee, Soon Il;
    • Chae, Yee Soo;
    • Yang, Deok-Hwan;
    • Kang, Hye Jin;
    • Choi, Chul Won;
    • Park, Jinny;
    • Kim, Hyo Jung;
    • Kwon, Jung Hye;
    • Lee, Ho Sup;
    • Lee, Gyeong-Won;
    • Eom, Hyeon Seok
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 5, p. 5558, doi. 10.1002/cam4.5400
    By:
    • Lee, Kyoungmin;
    • Park, In Hae;
    • Oh, Sang Cheul;
    • Seo, Jae Hong;
    • Jeon, Min Ji;
    • Yu, Eun Sang;
    • Kim, Dae Sik;
    • Choi, Chul Won;
    • Lim, Ah‐reum;
    • Hyun, Myung Han;
    • Kim, Ju Won;
    • Kim, Jwa Hoon;
    • Choi, Yoon Ji;
    • Lee, Soohyeon;
    • Park, Kyong Hwa;
    • Kim, Yeul Hong;
    • Choi, Jung Yoon;
    • Kim, Jung Sun;
    • Lee, Se Ryeon;
    • Sung, Hwa Jung
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 2, p. 303, doi. 10.1111/bjh.16381
    By:
    • Do, Young Rok;
    • Kwak, Jae‐Yong;
    • Kim, Jeong A.;
    • Kim, Hyeoung Joon;
    • Chung, Joo Seop;
    • Shin, Ho‐Jin;
    • Kim, Sung‐Hyun;
    • Bunworasate, Udomsak;
    • Choi, Chul Won;
    • Zang, Dae Young;
    • Oh, Suk Joong;
    • Jootar, Saengsuree;
    • Reksodiputro, Ary Harryanto;
    • Lee, Won Sik;
    • Mun, Yeung‐Chul;
    • Kong, Jee Hyun;
    • Caguioa, Priscilla B.;
    • Kim, Hawk;
    • Park, Jinny;
    • Kim, Dong‐Wook
    Publication type:
    Article